Cargando…
Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous, complex, and deadly disease, whose treatment has hardly evolved for decades and grounds on the use of intensive chemotherapy regimens. Chemotherapy helps reduce AML bulk, but promotes relapse in the long-run by selection of chemoresistant leukemia ste...
Autores principales: | Villatoro, Alicia, Konieczny, Joanna, Cuminetti, Vincent, Arranz, Lorena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367216/ https://www.ncbi.nlm.nih.gov/pubmed/32754595 http://dx.doi.org/10.3389/fcell.2020.00607 |
Ejemplares similares
-
Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells
por: Tan, Zhenya, et al.
Publicado: (2022) -
Bone Marrow Adipocytes: The Enigmatic Components of the Hematopoietic Stem Cell Niche
por: Cuminetti, Vincent, et al.
Publicado: (2019) -
Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer
por: Guyot, Boris, et al.
Publicado: (2022) -
The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy
por: Mosteo, Laura, et al.
Publicado: (2021) -
The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function
por: Isern, Joan, et al.
Publicado: (2014)